Edita B.

Edita B. is a highly experienced professional in process analytical technology and data science, currently serving as the Head of Process Analytical Technology & Data Science for continuous manufacturing of mRNA at Recipharm since July 2023. Prior roles include Director of Global Analytics (PAT) and Digital Innovation at Cytiva, and various managerial and scientific positions at Pall Corporation, Implant Sciences, Safran, Teva Pharmaceuticals, GlaxoSmithKline, Axsun Technologies, and Digilab, Inc. Edita possesses a PhD in Analytical Chemistry/Spectroscopy & Chemometrics from the University of Rhode Island and has completed the Harvard Business Analytics Program. Additionally, Edita holds a BA in Chemistry and Mathematics from Assumption University.